Clinical trial · Observational
Acute Kidney Injury Among Pediatric Cancer Patients At South Egypt Cancer Institute
NCT06081608CI-TRIAL-00070463unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Cancer is the second most frequent cause of premature death in children. The incidence of pediatric cancer varies by region and country, but it is generally considered rare with an estimated 300,000 new cases diagnosed worldwide. Acute kidney injury in pediatric cancer patients refers to the sudden and often temporary loss of renal function, which can lead to a variety of complications if not treated correctly.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| To Determine the Cumulative Incidence of AKI Using KDIGO Criteria in Pediatric Patients With Malignancy in South Egypt Cancer Institute (SECI) | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| kidney function test | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- To determine the cumulative incidence of AKI using KDIGO criteria in pediatric patients with malignancy in South Egypt Cancer Institute (SECI)
- timeFrame
- from November 2023 till November 2024
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 30 Days
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * • Children of both sexes (aged from 1 month to 18 years at diagnosis) * Patients with either hematological malignancies or solid tumors admitted to the Paediatric Oncology and Haematological Malignancies Department Exclusion Criteria: * Children who had an unconfirmed cancer diagnosis. * Children more than 18 years at diagnosis. * Children with preexisting chronic kidney disease (CKD) that defined as the presence of structural or functional kidney damage that persist over minimum of three month * The patient underwent hematopoietic stem cell transplantation. Patients with 1 s.Cr level. * Patient underwent renal transplant.
References
Publications (0)
Data not yet available
No reference posted for this study.